跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84,220 条关于
“HER2-mutant cancers”
全部
84,220
临床试验
72,124
药物
1,898
机构
298
资讯
9,900
2个月前
Enliven Therapeutics Advances ELVN-001 Toward Pivotal Phase 3 Trial in CML Amid Strong Financial Position
去年
Zongertinib Shows Promising Efficacy and Tolerability in HER2-Mutant NSCLC
去年
FDA Approves Boehringer Ingelheim's HERNEXEOS as First-in-Class HER2 TKI for Rare Lung Cancer Subset
11个月前
Zongertinib Shows 77% Response Rate in First-Line Treatment of HER2-Mutant Lung Cancer
去年
FDA Grants Priority Review to Boehringer's Zongertinib for HER2-Mutant Advanced Lung Cancer
去年
Engineered Antibody Precisely Targets Mutant HER2 in Cancer Cells
2年前
Advancements in HER2-Mutant NSCLC Therapies: A Pipeline Overview
去年
Lung Cancer Research Foundation and Boehringer Ingelheim Launch $2.25 Million Initiative to Target HER2-Mutant Lung Cancer
去年
Enhertu Shows Promise in Frontline HER2-Mutated NSCLC Treatment
2年前
Bayer's BAY 2927088 Shows Promise in HER2-Mutant NSCLC
第 1 页,共 990 页
上一页
下一页